CRAC channel is inhibited by neomycin in a Ptdlns(4,5)P2-independent manner

Kun Huang1, Xuemei Wang, Yanjun Liu

  • 1Department of Ultrasound, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.

Insights

Neomycin inhibits store-operated calcium entry via CRAC channels. This inhibition is independent of neomycin

Area of Science:

  • Cellular biology
  • Molecular pharmacology
  • Ion channel physiology

Background:

  • Store-operated calcium entry (SOCE) is crucial for cellular calcium homeostasis.
  • Calcium release-activated calcium (CRAC) channels mediate SOCE.
  • Neomycin, an aminoglycoside, is known to bind phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2).

Purpose of the Study:

  • To investigate the mechanism by which neomycin inhibits CRAC channel activity.
  • To determine the role of PtdIns(4,5)P2 in neomycin-mediated inhibition of CRAC channels.

Main Methods:

  • Patch clamp electrophysiology to record CRAC currents.
  • Co-expression of Orai1 and Stim1 in HEK293 cells to reconstitute CRAC channels.
  • Utilizing a rapamycin-inducible PtdIns(4,5)P2-specific phosphatase (Inp54p) system to manipulate plasma membrane PtdIns(4,5)P2 levels.

Main Results:

  • Neomycin inhibited CRAC currents reconstituted by Orai1 and Stim1.
  • Depletion of PtdIns(4,5)P2 using the Inp54p system did not alter CRAC channel activity.
  • Neomycin's inhibition of CRAC channels was independent of its binding to PtdIns(4,5)P2.

Conclusions:

  • Phosphatidylinositol 4,5-bisphosphate is not required for CRAC channel function.
  • Neomycin inhibits CRAC channels through a mechanism independent of PtdIns(4,5)P2 binding.